Stewart Appelrouth, Director at AIM ImmunoTech Inc. (AIM), bought 11,112 shares at $0.21 ($2K) on 2024-12-02, disclosed to the SEC on 2024-12-04.
Open-market purchase of $2k AIM by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.21 | 1 | $0 | 0.0% |
| 2 | $0.21 | 11,111 | $2K | 100.0% |
| Total | $0.21 avg | 11,112 | $2K | 100% |
| Filing → |
| AIM | BUY | 2023-01-04 | $25K | — | Filing → |
| AIM | BUY | 2021-02-25 | $25K | — | Filing → |
| HEB | BUY | 2019-06-25 | $39K | — | Filing → |